Adage Capital Partners Gp, L.L.C. Axogen, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$12.09 - $20.46 $1.81 Million - $3.07 Million	-150,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $3.7 Million - $5.09 Million	-200,000 Reduced 57.14%	150,000 $2.97 Million
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $5.12 Million - $7.75 Million	350,000 New	350,000 $7.37 Million

176

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $749M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.